ArticleActa diabetologica2022

Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis.

Chen Ding et al.PubMed ↗Publisher ↗

No numbers read from the abstract.